Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Smesny

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Psychopharmacology|November 26, 2009
GSK3B and schizophrenia: a case not closedPhilipp G Sand, Martina Domani, Stefan Smesny
Biological Psychiatry|January 12, 2010
Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophreniaPhilipp G Sand, Martina Domani, Stefan Smesny
International Review of Psychiatry (Abingdon, England)|June 17, 2006
Bioactive lipids in schizophreniaGregor E Berger, Stefan Smesny, G Paul Amminger
Schizophrenia Bulletin|February 8, 2011
Aging effects on regional brain structural changes in schizophreniaIgor Nenadić, Heinrich Sauer, Stefan Smesny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2004
Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100mTimm Rosburg, Varvara Marinou, Jens Haueisen, et al.
Journal of Affective Disorders|February 2, 2010
Alterations of niacin skin sensitivity in recurrent unipolar depressive disorderStefan Smesny, Kati Baur, Nicole Rudolph, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2007
Cannabinoids influence lipid-arachidonic acid pathways in schizophreniaStefan Smesny, Timm Rosburg, Kati Baur, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2003
Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophreniaJürgen Lasch, Ingo Willhardt, Daniel Kinder, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2008
Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementiaStefan Smesny, Susan Stein, Ingo Willhardt, et al.
Psychiatry Research|May 31, 2002
Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groupsStefan Riehemann, Gabriele Hübner, Stefan Smesny, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Psychopharmacology|November 26, 2009
GSK3B and schizophrenia: a case not closedPhilipp G Sand, Martina Domani, Stefan Smesny
Biological Psychiatry|January 12, 2010
Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophreniaPhilipp G Sand, Martina Domani, Stefan Smesny
International Review of Psychiatry (Abingdon, England)|June 17, 2006
Bioactive lipids in schizophreniaGregor E Berger, Stefan Smesny, G Paul Amminger
Schizophrenia Bulletin|February 8, 2011
Aging effects on regional brain structural changes in schizophreniaIgor Nenadić, Heinrich Sauer, Stefan Smesny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2004
Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100mTimm Rosburg, Varvara Marinou, Jens Haueisen, et al.
Journal of Affective Disorders|February 2, 2010
Alterations of niacin skin sensitivity in recurrent unipolar depressive disorderStefan Smesny, Kati Baur, Nicole Rudolph, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2007
Cannabinoids influence lipid-arachidonic acid pathways in schizophreniaStefan Smesny, Timm Rosburg, Kati Baur, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2003
Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophreniaJürgen Lasch, Ingo Willhardt, Daniel Kinder, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2008
Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementiaStefan Smesny, Susan Stein, Ingo Willhardt, et al.
Psychiatry Research|May 31, 2002
Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groupsStefan Riehemann, Gabriele Hübner, Stefan Smesny, et al.
Pageof 10